Psychedelic Business Spotlight – April 8
This week in psychedelic business news: Field Trip Health secures a patent; Core One Labs seeks more retail investors; a new CEO takes over GABA Therapeutics.
core one labs
Another Psychedelics Company Is Crashing
Core One Labs appears to be following in footsteps of Mind Cure, but that doesn’t mean the entire psychedelics industry is in trouble.
Psychedelic Business Spotlight- March 11
This week in psychedelic business news: Small Pharma prepares big DMT studies; Health Canada approves a psilocybin PTSD study.
Psychedelic Business Spotlight – February 25
This week in psychedelic business news: Core One cheapens psilocybin production; Field Trip eyes Oregon; Small Pharma advances DMT.
Psychedelic Business Spotlight – February 11
This week in psychedelic business news: Cybin scores another patent; another huge psychedelics conference heads to Miami; Core One Labs widens pipeline with another drug.
Psychedelic Business Spotlight – December 31
This week in psychedelic business news: Mindset Pharma files another patent for compounds with “perfect microdosing drug profile,” and Core One Labs is preparing to capitalize on functional mushroom market.
Psychedelic Business Spotlight: August 13, 2021
This week in psychedelic business news: Psychedelics in development to treat eye diseases and stroke; companies gear up for new clinical trials investigating psychedelics for general anxiety, chronic pain, and eating disorders.
Third Psychedelic Stock ETF Coming Soon, Core One Labs Prepares to List on NASDAQ
Advisorshares Plant Medicine ETF will be listed on the NYSE Arca under the symbol PSIL.
End of content
End of content